Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

Francesca Prete, Marco Catucci, Mayrel Labrada, Stefania Gobessi, Maria Carmina Castiello, Elisa Bonomi, Alessandro Aiuti, William Vermi, Caterina Cancrini, Ayse Metin, Sophie Hambleton, Robbert Bredius, Luigi Daniele Notarangelo, Mirjam van der Burg, Ulrich Kalinke, Anna Villa, Federica Benvenuti

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Mutations in Wiskott-Aldrich syndrome (WAS) protein (WASp), a regulator of actin dynamics in hematopoietic cells, cause WAS, an X-linked primary immunodeficiency characterized by recurrent infections and a marked predisposition to develop autoimmune disorders. The mechanisms that link actin alterations to the autoimmune phenotype are still poorly understood. We show that chronic activation of plasmacytoid dendritic cells (pDCs) and elevated type-I interferon (IFN) levels play a role in WAS autoimmunity. WAS patients display increased expression of type-I IFN genes and their inducible targets, alteration in pDCs numbers, and hyperresponsiveness to TLR9. Importantly, ablating IFN-I signaling in WASp null mice rescued chronic activation of conventional DCs, splenomegaly, and colitis. Using WASp-deficient mice, we demonstrated that WASp null pDCs are intrinsically more responsive to multimeric agonist of TLR9 and constitutively secrete type-I IFN but become progressively tolerant to further stimulation. By acute silencing of WASp and actin inhibitors, we show that WASp-mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in pDCs restraining exaggerated activation of the TLR9-IFN-α pathway. Together, these data highlight the role of actin dynamics in pDC innate functions and imply the pDC-IFN-α axis as a player in the onset of autoimmune phenomena in WAS disease.

Original languageEnglish
Pages (from-to)355-374
Number of pages20
JournalJournal of Experimental Medicine
Volume210
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Wiskott-Aldrich Syndrome Protein
Interferon Type I
Wiskott-Aldrich Syndrome
Dendritic Cells
Actins
Interferons
Proteins
Splenomegaly
Colitis
Autoimmunity
Polymerization
Cell Count
Ligands
Phenotype
Mutation
Infection
Genes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells. / Prete, Francesca; Catucci, Marco; Labrada, Mayrel; Gobessi, Stefania; Castiello, Maria Carmina; Bonomi, Elisa; Aiuti, Alessandro; Vermi, William; Cancrini, Caterina; Metin, Ayse; Hambleton, Sophie; Bredius, Robbert; Notarangelo, Luigi Daniele; van der Burg, Mirjam; Kalinke, Ulrich; Villa, Anna; Benvenuti, Federica.

In: Journal of Experimental Medicine, Vol. 210, No. 2, 02.2013, p. 355-374.

Research output: Contribution to journalArticle

Prete, F, Catucci, M, Labrada, M, Gobessi, S, Castiello, MC, Bonomi, E, Aiuti, A, Vermi, W, Cancrini, C, Metin, A, Hambleton, S, Bredius, R, Notarangelo, LD, van der Burg, M, Kalinke, U, Villa, A & Benvenuti, F 2013, 'Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells', Journal of Experimental Medicine, vol. 210, no. 2, pp. 355-374. https://doi.org/10.1084/jem.20120363
Prete, Francesca ; Catucci, Marco ; Labrada, Mayrel ; Gobessi, Stefania ; Castiello, Maria Carmina ; Bonomi, Elisa ; Aiuti, Alessandro ; Vermi, William ; Cancrini, Caterina ; Metin, Ayse ; Hambleton, Sophie ; Bredius, Robbert ; Notarangelo, Luigi Daniele ; van der Burg, Mirjam ; Kalinke, Ulrich ; Villa, Anna ; Benvenuti, Federica. / Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells. In: Journal of Experimental Medicine. 2013 ; Vol. 210, No. 2. pp. 355-374.
@article{ccf214677a6b474491e9071b0c9068ba,
title = "Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells",
abstract = "Mutations in Wiskott-Aldrich syndrome (WAS) protein (WASp), a regulator of actin dynamics in hematopoietic cells, cause WAS, an X-linked primary immunodeficiency characterized by recurrent infections and a marked predisposition to develop autoimmune disorders. The mechanisms that link actin alterations to the autoimmune phenotype are still poorly understood. We show that chronic activation of plasmacytoid dendritic cells (pDCs) and elevated type-I interferon (IFN) levels play a role in WAS autoimmunity. WAS patients display increased expression of type-I IFN genes and their inducible targets, alteration in pDCs numbers, and hyperresponsiveness to TLR9. Importantly, ablating IFN-I signaling in WASp null mice rescued chronic activation of conventional DCs, splenomegaly, and colitis. Using WASp-deficient mice, we demonstrated that WASp null pDCs are intrinsically more responsive to multimeric agonist of TLR9 and constitutively secrete type-I IFN but become progressively tolerant to further stimulation. By acute silencing of WASp and actin inhibitors, we show that WASp-mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in pDCs restraining exaggerated activation of the TLR9-IFN-α pathway. Together, these data highlight the role of actin dynamics in pDC innate functions and imply the pDC-IFN-α axis as a player in the onset of autoimmune phenomena in WAS disease.",
author = "Francesca Prete and Marco Catucci and Mayrel Labrada and Stefania Gobessi and Castiello, {Maria Carmina} and Elisa Bonomi and Alessandro Aiuti and William Vermi and Caterina Cancrini and Ayse Metin and Sophie Hambleton and Robbert Bredius and Notarangelo, {Luigi Daniele} and {van der Burg}, Mirjam and Ulrich Kalinke and Anna Villa and Federica Benvenuti",
year = "2013",
month = "2",
doi = "10.1084/jem.20120363",
language = "English",
volume = "210",
pages = "355--374",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

AU - Prete, Francesca

AU - Catucci, Marco

AU - Labrada, Mayrel

AU - Gobessi, Stefania

AU - Castiello, Maria Carmina

AU - Bonomi, Elisa

AU - Aiuti, Alessandro

AU - Vermi, William

AU - Cancrini, Caterina

AU - Metin, Ayse

AU - Hambleton, Sophie

AU - Bredius, Robbert

AU - Notarangelo, Luigi Daniele

AU - van der Burg, Mirjam

AU - Kalinke, Ulrich

AU - Villa, Anna

AU - Benvenuti, Federica

PY - 2013/2

Y1 - 2013/2

N2 - Mutations in Wiskott-Aldrich syndrome (WAS) protein (WASp), a regulator of actin dynamics in hematopoietic cells, cause WAS, an X-linked primary immunodeficiency characterized by recurrent infections and a marked predisposition to develop autoimmune disorders. The mechanisms that link actin alterations to the autoimmune phenotype are still poorly understood. We show that chronic activation of plasmacytoid dendritic cells (pDCs) and elevated type-I interferon (IFN) levels play a role in WAS autoimmunity. WAS patients display increased expression of type-I IFN genes and their inducible targets, alteration in pDCs numbers, and hyperresponsiveness to TLR9. Importantly, ablating IFN-I signaling in WASp null mice rescued chronic activation of conventional DCs, splenomegaly, and colitis. Using WASp-deficient mice, we demonstrated that WASp null pDCs are intrinsically more responsive to multimeric agonist of TLR9 and constitutively secrete type-I IFN but become progressively tolerant to further stimulation. By acute silencing of WASp and actin inhibitors, we show that WASp-mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in pDCs restraining exaggerated activation of the TLR9-IFN-α pathway. Together, these data highlight the role of actin dynamics in pDC innate functions and imply the pDC-IFN-α axis as a player in the onset of autoimmune phenomena in WAS disease.

AB - Mutations in Wiskott-Aldrich syndrome (WAS) protein (WASp), a regulator of actin dynamics in hematopoietic cells, cause WAS, an X-linked primary immunodeficiency characterized by recurrent infections and a marked predisposition to develop autoimmune disorders. The mechanisms that link actin alterations to the autoimmune phenotype are still poorly understood. We show that chronic activation of plasmacytoid dendritic cells (pDCs) and elevated type-I interferon (IFN) levels play a role in WAS autoimmunity. WAS patients display increased expression of type-I IFN genes and their inducible targets, alteration in pDCs numbers, and hyperresponsiveness to TLR9. Importantly, ablating IFN-I signaling in WASp null mice rescued chronic activation of conventional DCs, splenomegaly, and colitis. Using WASp-deficient mice, we demonstrated that WASp null pDCs are intrinsically more responsive to multimeric agonist of TLR9 and constitutively secrete type-I IFN but become progressively tolerant to further stimulation. By acute silencing of WASp and actin inhibitors, we show that WASp-mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in pDCs restraining exaggerated activation of the TLR9-IFN-α pathway. Together, these data highlight the role of actin dynamics in pDC innate functions and imply the pDC-IFN-α axis as a player in the onset of autoimmune phenomena in WAS disease.

UR - http://www.scopus.com/inward/record.url?scp=84874577141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874577141&partnerID=8YFLogxK

U2 - 10.1084/jem.20120363

DO - 10.1084/jem.20120363

M3 - Article

VL - 210

SP - 355

EP - 374

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -